FNAM OTC
Evolutionary Genomics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$641K
+59.5% ▲
Capital Expenditures
$3
+0.0% ▲
Free Cash Flow
-$641K
+59.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$363K
+19971.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$793K | -$2M | -$3M | -$2M |
| Depreciation & Amort. | $41K | $41K | $409K | $1M | $1M |
| Stock-Based Comp. | $99K | $56K | $220K | $220K | $193K |
| Change in Working Capital | -$52K | $52K | -$47K | $36K | $79K |
| Other Non-Cash Items | $263K | -$13K | -$180K | -$83K | $0 |
| Operating Cash Flow | -$749K | -$626K | -$2M | -$2M | -$641K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | -$3 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $148K | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $3 |
| Investing Cash Flow | $0 | $0 | $148K | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $2M | $2M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$242K | $0 | $0 | $0 | $0 |
| Other Financing | $242K | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$242K | $540K | $2M | $2M | $1M |
| Net Change in Cash | -$749K | -$86K | $170K | -$2K | $363K |
| Cash End of Period | $131K | $45K | $216K | $214K | $577K |
| Free Cash Flow | -$749K | -$626K | -$2M | -$2M | -$641K |